University of Alabama at Birmingham (UAB) Comprehensive Cancer Center

Birmingham, Alabama 35294

We've found

3 trials

at this facility

Phase IIB TL + YCWP + DC in Melanoma

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Birmingham, AL

A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study

Status: Enrolling, Phase IV
Updated: 12/31/1969

from

Birmingham, AL

Trial of Hu5F9-G4 in Combination With Rituximab in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Birmingham, AL

Use our guide to learn which trials are right for you!